478 search results for “protoplanetary drug” in the Staff website
-
Lukasz TychoniecFaculty of Science
-
Leiden researchers pioneer ‘green’ framework for sustainable drug development
Medical drugs are expensive to make and can have an adverse effect on the environment. Researchers Stefano Cucurachi and Justin Lian have developed a framework to help the healthcare system assess the economic and environmental sustainability of medical compounds.
-
Better understanding of cancer drugs – Leiden spin-off Omivera receives seed investment
How do you know if a drug will actually work? The Leiden-based spin-off Omivera is developing a new technology that could provide clearer answers. The young company received a seed investment from the investment fund UNIIQ to support its development.
-
Peter BouwmanFaculty of Science
-
Hildert BronkhorstFaculty of Science
-
New platform to accelerate cardiac drug development
Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform that enables the automated production of 3D cardiac microtissues. This platform will allow large numbers of drugs to be tested quickly
-
Oncode Accelerator launched: patients at the centre of innovative cancer drug development
Providing each cancer patient with the right treatment remains a challenge. Oncode Accelerator aims to change this by innovating the way we develop cancer treatments, thus ensuring the patient is at the heart of the process.
-
Giulia CallegaroFaculty of Science
-
Bob van de WaterFaculty of Science
-
Alexander KrosFaculty of Science
-
Gerard van WestenFaculty of Science
-
Drugs for our immune system in the right place at the right time
Immunologist Leender Trouw specialises in the complement system, which is part of the immune system. In some diseases drugs help activate or inhibit this system. This is best done ‘in the right place at the right time’ − the title of his inaugural lecture.
-
Laura HeitmanFaculty of Science
-
Skin researcher calls for multidisciplinary collaboration: ‘I want to pool expertise’
In dermatology, there should be a high level of multidisciplinary collaboration among institutes and specialists, Professor of Translational Dermatology, Robert Rissmann, will say in his inaugural lecture on 8 July. He is building an infrastructure that will put pre-clinical and clinical skin research…
-
Meiling GaoFaculty of Science
-
Eline DekeysterFaculty of Social and Behavioural Sciences
-
How Leiden University is taking action against cancer
One in two people will be diagnosed with cancer. World Cancer Day on 4 February raises awareness of the impact of this devastating disease. Leiden University is conducting various studies aimed at preventing and controlling cancer. Below are just a few examples.
-
Madeline KavanaghFaculty of Science
-
Marije NiemeijerFaculty of Science
-
Bas ter BraakFaculty of Science
-
UMCs join forces to increase pandemic preparedness
Four university medical centres, including the LUMC, are joining forces to increase pandemic preparedness in the Netherlands.
-
Mario van der SteltFaculty of Science
-
Margo DonaFaculty of Science
-
Laura de JongFaculty of Science
-
RARE-NL: LUMC joins consortium to find treatments for rare diseases
RARE-NL, a new collaboration between university hospitals, hopes to find treatments for rare diseases. Professor Teun van Gelder is representing the LUMC in the initiative.
-
Erik DanenFaculty of Science
-
Roxanne KieltykaFaculty of Science
-
Sebastian PomplunFaculty of Science
-
Coen van HasseltFaculty of Science
-
Anthe JanssenFaculty of Science
-
ICT-contact persons
For each university unit, the ICT Shared Service Centre (ISSC) has an appointed ICT contact person responsible for applying for ICT facilities for research, teaching and operational management.
-
Serkan AslanFaculty of Science
-
Leiden scientists join national effort to advance nanomedicine
A Dutch consortium has received €6.7 million to accelerate the development of nanomedicines together with patients. Researchers from Leiden University play a key role in the project.
-
Thomas HankemeierFaculty of Science
-
Vici grants for research into antibodies, galaxies and Indigenous communities
Three Leiden researchers have been awarded a Vici grant by the Dutch Research Council. The funding of up to 1.5 million euros supports ‘talented, adventurous and pioneering researchers’. A total of 39 projects at Dutch institutions will receive a grant.
-
Olivier BéquignonFaculty of Science
-
Medical Delta AI for Computational Life Sciences
The fact that scientists are increasingly better able to access molecular cell and tissue data also brings with it a new challenge: how can scientists find the information they need for research among the vast amount of data available?
-
Doctors discover a simple method to predict the risk of brain tumour recurrence
The risk of a brain tumour recurring can be predicted more accurately by counting the number of immune cells in the tumour under a microscope. These are the findings from research conducted by LUMC, Erasmus MC and Heidelberg University.
-
Is a cancer pill a matter of time?
A cancer pill, preferably without severe side effects, is something we’d all welcome. Is it a matter of time before such a pill is a reality? We put this question to three Leiden researchers and asked how they themselves are contributing to new cancer treatments.
-
Daisy BatenburgFaculty of Science
-
Andraniek EvadgianFaculty of Science
-
Kim ElbertseFaculty of Science
-
Elsa NeubertFaculty of Science
-
Irene Pascual GarciaFaculty of Science
-
Rob van WijkFaculty of Science
-
Myrtille KoerselmanFaculty of Science
-
Rosan KuinFaculty of Science
-
Kostas Tassis
Faculty of Science
-
Leo Price
Faculty of Science
-
Martijn Moné
Faculty of Science